Task: Answer the multiple-choice question.
Question: Which drug exhibits a 28.153% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a.) C/C(=N\NC(=O)c1ccccc1)c1ccc(N2CCCCC2)cc1
b.) COc1ccc(CC(=O)N2CCN(c3cccc(Cl)c3)CC2)cc1OC
c.) CSc1ccc(Cl)c(C(=O)NCCCn2ccnc2)c1
d.) COc1cc(NC(=O)CN2CCN(c3ccccc3F)CC2)c(C)cc1[N+](=O)[O-]
e.) O=C(Nc1ccc2c(c1)OCO2)c1cnc2n(c1=O)CCS2
Answer: d. COc1cc(NC(=O)CN2CCN(c3ccccc3F)CC2)c(C)cc1[N+](=O)[O-]
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1cc(NC(=O)CN2CCN(c3ccccc3F)CC2)c(C)cc1[N+](=O)[O-]
COc1cc(NC(=O)CN2CCN(c3ccccc3F)CC2)c(C)cc1[N+](=O)[O-]
2-[4-(2-fluorophenyl)piperazin-1-yl]-N-(5-methoxy-2-methyl-4-nitrophenyl)acetamide